ApoA1: Mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in hemeoxygenase (HO-1) and Wnt10b

Cell Cycle

Volumn 11, Issue 4, 2012, Pages 706-714

  Vanella, Luca ^a,c   Li, Ming ^a,e   Kim, DongHyun ^a   Malfa, Giuseppe ^a   Bellner, Lars ^b   Kawakami, Tomoko ^a,d   Abraham, Nader G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

^d OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

BMP2; Diabetes; Heme oxygenase; Osteoblasts; Osteoporosis

Indexed keywords

ADIPONECTIN; FAS ANTIGEN; GLUCOSE; HEME OXYGENASE 1; INSULIN RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 6; WNT10B PROTEIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; IN VITRO STUDY; IN VIVO STUDY; INSULIN SENSITIVITY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

MUS;

EID: 84863116507     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.4.19125     Document Type: Article

References (26)

1. Schulz E, Dopheide J, Schuhmacher S, Thomas SR, Chen K, Daiber A, et al. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 2008; 118:1347-57; PMID:18809807.
2. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-10; PMID:8647954; http://dx.doi. org/10.1172/JCI118709.
3. Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J Diabetes Complications 2007; 21:149-57; PMID:17493547; http://dx.doi.org/10.1016/j. jdiacomp. 2005.12.003.
4. Hall JE. The kidney, hypertension and obesity. Hypertension 2003; 41:625-33; PMID:12623970; http://dx.doi.org/10.1161/01. HYP.0000052314.95497.78.
5. Sodhi K, Inoue K, Gotlinger KH, Canestraro M, Vanella L, Kim DH, et al. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Ther 2009; 331:906-16; PMID:19717790; http://dx.doi. org/10.1124/jpet.109.157545.
6. Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF, et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK and pAKT in obese mice. J Lipid Res 2009; 50:1293-304; PMID:19224872; http://dx.doi. org/10.1194/jlr.M800610-JLR200.
7. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S, et al. L-4F treatment reduces adiposity, increases adiponectin levels and improves insulin sensitivity in obese mice. J Lipid Res 2008; 49:1658-69; PMID:18426778; http://dx.doi.org/10.1194/jlr. M800046-JLR200.
8. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008; 57:1526-35; PMID:18375438; http://dx.doi.org/10.2337/db07-1764.
9. Hirsch J, Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 1976; 5:299- 311; PMID:1085232; http://dx.doi.org/10.1016/ S0300-595X(76)80023-0.
10. Roncari DA, Lau DC, Kindler S. Exaggerated replication in culture of adipocyte precursors from massively obese persons. Metabolism 1981; 30:425-7; PMID:7231183; http://dx.doi.org/10.1016/0026-0495(81)90174-8.
11. Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab 2009; 20:107-14; PMID:19269847; http://dx.doi.org/10.1016/j. tem.2008.11.005.
12. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell 2007; 131:242-56; PMID:17956727; http://dx.doi.org/10.1016/ j. cell.2007.10.004.
13. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272:263-7; PMID:8602510; http://dx.doi.org/10.1126/ science.272.5259.263.
14. Lecka-Czernik B, Rosen CJ, Kawai M. Skeletal aging and the adipocyte program: New insights from an "old" molecule. Cell Cycle 2010; 9:3648-54; PMID:20890120; http://dx.doi.org/10.4161/cc.9.18.13046.
15. Zafren K, Feldman J, Becker RJ, Williams SR, Weiss EA, Deloughery T. D-dimer is not elevated in asymptomatic high altitude climbers after descent to 5,340?m: the Mount Everest Deep Venous Thrombosis Study (Ev-DVT). High Alt Med Biol 2011; 12:223-7; PMID:21962065; http://dx.doi.org/10.1089/ ham.2010.1101.
16. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006; 47:1108-16; PMID:16651465; http://dx.doi. org/10.1161/01.HYP.0000222368. 43759.a1.
17. Wang ZV, Scherer PE. Adiponectin, cardiovascular function and hypertension. Hypertension 2008; 51:8-14; PMID:17998473; http://dx.doi.org/10. 1161/HYPERTENSIONAHA.107.099424.
18. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002; 51:2325-8; PMID:12086969; http://dx.doi. org/10.2337/diabetes.51.7.2325.
19. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) 2003; 228:1111-7; PMID:14610248.
20. Kotani K, Sakane N, Saiga K, Kurozawa Y. Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia 2005; 48:2684-6; PMID:16261311; http://dx.doi.org/10.1007/s00125-005-0015-4.
21. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752-61; PMID:15599400.
22. Choo HJ, Kim JH, Kwon OB, Lee CS, Mun JY, Han SS, et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 2006; 49:784-91; PMID:16501941; http://dx.doi.org/10.1007/s00125-006-0170-2.
23. Vanella L, Kim DH, Sodhi K, Barbagallo I, Burgess AP, Falck JR, et al. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat 2011; 96:54-62; PMID:21821145; http://dx.doi.org/10.1016/j. prostaglandins. 2011.07.005.
24. Keating A. Mesenchymal stromal cells. Curr Opin Hematol 2006; 13:419-25; PMID:17053453; http://dx.doi.org/10.1097/01.moh.0000245697.54887.6f.
25. Vanella L, Kim DH, Asprinio D, Peterson SJ, Barbagallo I, Vanella A, et al. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone 2010; 46:236-43; PMID:19853072; http://dx.doi.org/10.1016/j. bone.2009.10.012.
26. Yu F, Takahashi T, Moriya J, Kawaura K, Yamakawa J, Kusaka K, et al. Angiotensin-II receptor antagonist alleviates non-alcoholic fatty liver in KKAy obese mice with type 2 diabetes. J Int Med Res 2006; 34:297-302; PMID:16866024.